FDA product code KKH: Tablet, Resazurin

KKH is the FDA product code for tablet, resazurin. It is a Class I device, regulated under 21 CFR 864.1850 and reviewed by the Pathology panel. Devices under KKH reach the market by 510(k) exempt; FDA lists no cleared 510(k)s for it. FDA has posted 1 recall for KKH devices, 1 initiated in the last five years.

Classification

FieldValue
Device nameTablet, Resazurin
Device classClass I
Regulation21 CFR 864.1850
Review panelPA — Pathology
Medical specialtyHematology
Premarket route510(k) exempt
GMP exemptYes

Recalls for KKH devices

1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2022-05-25.

YearRecalls
20221

Frequently asked questions

What is FDA product code KKH?

KKH is the FDA product code for tablet, resazurin. It is a Class I device, regulated under 21 CFR 864.1850 and reviewed by the Pathology panel.

What device class is KKH?

Class I, regulation 21 CFR 864.1850. Typical premarket route: 510(k) exempt.

Have KKH devices been recalled?

Yes: 1 product recalls across 1 recall events; the most recent began 2022-05-25.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times